Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from EPE Special Opportunities ( (GB:ESO) ) is now available.
EPE Special Opportunities reported a 10% rise in net asset value per share to 360 pence for the year to 31 January 2026, despite a challenging macroeconomic backdrop. The share price edged up to 150 pence but continues to trade at a significant discount to NAV, which the board is addressing through portfolio diversification, scale, and ongoing share buybacks.
Portfolio performance was underpinned by strong trading at Luceco, Whittard, Rayware, Pharmacy2U, and Denzel’s, including accretive bolt-on acquisition LSA International and continued growth in EV charging and online healthcare services. The company reinforced its balance sheet, ending the period with £14.1 million in cash, refinancing Whittard, extending unsecured loan notes, and repurchasing both ordinary and zero dividend preference shares while maintaining low leverage across its largely unquoted holdings.
The most recent analyst rating on (GB:ESO) stock is a Hold with a £174.00 price target. To see the full list of analyst forecasts on EPE Special Opportunities stock, see the GB:ESO Stock Forecast page.
Spark’s Take on ESO Stock
According to Spark, TipRanks’ AI Analyst, ESO is a Neutral.
The score is held back primarily by volatile profitability and uneven cash-flow history, despite a comparatively solid balance sheet. Technically the stock trends slightly positive versus moving averages, but overbought momentum indicators add near-term risk. Valuation is difficult to support with a negative P/E and no dividend yield data, while recent buybacks provide only a modest positive.
To see Spark’s full report on ESO stock, click here.
More about EPE Special Opportunities
EPE Special Opportunities Limited is an investment company focused on private equity-style opportunities, backing growth and transformational businesses across consumer, healthcare, and industrial sectors. Its portfolio includes holdings such as Luceco, Whittard of Chelsea, Rayware, Pharmacy2U, and Denzel’s, with an emphasis on value creation, disciplined leverage, and capital structure management.
Average Trading Volume: 36,344
Technical Sentiment Signal: Buy
For an in-depth examination of ESO stock, go to TipRanks’ Overview page.